Clinical Trial Update: Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer [NA]

View source ↗

Summary

A clinical trial comparing moxifloxacin with ciprofloxacin plus amoxicillin for fever and neutropenia in cancer patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms
• Neutropenia

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Chronic Myeloproliferative Disorders, Fever, Sweats, and Hot Flashes | NA | Status: TERMINATED